Cargando…
Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology
Vaccinia-based systems have been extensively explored for the development of recombinant vaccines. Herein we describe an innovative vaccinia virus (VACV)-derived vaccine platform technology termed Sementis Copenhagen Vector (SCV), which was rendered multiplication-defective by targeted deletion of t...
Autores principales: | Eldi, Preethi, Cooper, Tamara H., Liu, Liang, Prow, Natalie A., Diener, Kerrilyn R., Howley, Paul M., Suhrbier, Andreas, Hayball, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628773/ https://www.ncbi.nlm.nih.gov/pubmed/28720468 http://dx.doi.org/10.1016/j.ymthe.2017.06.017 |
Ejemplares similares
-
The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates
por: Prow, Natalie A., et al.
Publicado: (2020) -
A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
por: Prow, Natalie A., et al.
Publicado: (2018) -
Uterine B Cells Exhibit Regulatory Properties During the Peri-Implantation Stage of Murine Pregnancy
por: Guzman-Genuino, Ruth Marian, et al.
Publicado: (2019) -
The vaccinia‐based Sementis Copenhagen Vector coronavirus disease 2019 vaccine induces broad and durable cellular and humoral immune responses
por: Eldi, Preethi, et al.
Publicado: (2022) -
Chikungunya virus transmission between Aedes albopictus and laboratory mice
por: Hugo, Leon E., et al.
Publicado: (2016)